Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Observational 3

Sponsor

Cancer Type

Classical hematology 3

Conditions

Breast Neoplasms 13132Neoplasms 10477Carcinoma, Non-Small-Cell Lung 6870Prostatic Neoplasms 6268Colorectal Neoplasms 5945Lung Neoplasms 5102Multiple Myeloma 3576Pancreatic Neoplasms 3561Leukemia, Myeloid, Acute 3510Neoplasm Metastasis 3507Carcinoma, Hepatocellular 3271Ovarian Neoplasms 3168Melanoma 3139Stomach Neoplasms 3056Lymphoma 2982Head and Neck Neoplasms 2603Recurrence 2556Precursor Cell Lymphoblastic Leukemia-Lymphoma 2499Leukemia 2362Colonic Neoplasms 2327Brain Neoplasms 2310Lymphoma, Non-Hodgkin 2268Rectal Neoplasms 2191Uterine Cervical Neoplasms 2191Glioblastoma 2014Leukemia, Lymphocytic, Chronic, B-Cell 1992Carcinoma, Renal Cell 1913Squamous Cell Carcinoma of Head and Neck 1880Lymphoma, Follicular 1847Esophageal Neoplasms 1800

Interventions

Rivaroxaban 3Heparin, Low-Molecular-Weight 3acarboxyprothrombin 1N(4)-oleylcytosine arabinoside 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Treatment of Venous Thromboembolism in Cancer Patients × Clear all
NCT04979780 2024-10-31

OSCAR-US

Bayer

Completed
3,708 enrolled
Classical hematology

Treatment of Venous Thromboembolism in Cancer Patients

NCT05150938 2023-12-18

A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)

Bayer

Completed
5,737 enrolled
Classical hematology

Treatment of Venous Thromboembolism in Cancer Patients

NCT05112666 2023-04-03

A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)

Bayer

Completed
2,601 enrolled
Classical hematology

Treatment of Venous Thromboembolism in Cancer Patients

Data powered by HemOnc (CC BY 4.0) Colophon âš¡